Skip to page body Patient Care Survivorship Research Cancer Types News Giving Community Partners Clinical Trials
UCLA's Jonsson Comprehensive Cancer Center
Take the Jonsson Cancer Center Site Survey

JCCC Member Directory

Yong Kim, Ph.D.
Yong Kim, Ph.D.

Affiliation(s):

Associate Professor, Department of Oral Biology and Medicine
Member, JCCC Cancer and Stem Cell Biology Program Area

Contact Information:

Phone:
(310) 825-7210
Email:

Scientific Interest(s):

Dr. Yong Kim's research is focused on cell cycle regulation and epigenetic regulation in cancer cells and in stem cell maintenance/differentiation.

Selected Cancer-Related Publications:

Peng H, Shintani S, Kim Y, Wong DT. Loss of p12CDK2-AP1 expression in human oral squamous cell carcinoma with disrupted transforming growth factor-beta-Smad signaling pathway. Neoplasia. 2006 Dec;8(12):1028-36.

Kim Y, Ohyama H, Patel V, Figueiredo M, Wong DT. Mutation of Cys105 inhibits dimerization of p12CDK2-AP1 and its growth suppressor effect. J Biol Chem. 2005 Jun 17;280(24):23273-9. Epub 2005 Apr 19.

Figueiredo ML, Kim Y, St John MA, Wong DT. p12CDK2-AP1 gene therapy strategy inhibits tumor growth in an in vivo mouse model of head and neck cancer. Clin Cancer Res. 2005 May 15;11(10):3939-48.

Kim Y, McBride J, Zhang R, Zhou X, Wong DT. p12(CDK2-AP1) mediates DNA damage responses induced by cisplatin. Oncogene. 2005 Jan 13;24(3):407-18.

Kim Y, Shintani S, Kohno Y, Zhang R, Wong DT. Cyclin G2 dysregulation in human oral cancer. Cancer Res. 2004 Dec 15;64(24):8980-6.